2026-2030年全球照護現場血糖檢測市場

全球即時血糖監測市場預計在 2025 年至 2030 年間成長至 9.932 億美元，預測期內複合年成長率為 5.1%。

這份關於全球即時血糖監測市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球糖尿病和代謝性疾病盛行率的上升、臨床環境中持續血糖監測的日益普及、醫療服務的去中心化以及門診服務的擴展。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，多參數即時檢測感測器的發展是未來幾年全球即時血糖檢測市場成長的關鍵促進因素之一。此外，預測性人工智慧和分析技術的融合，以及向全自動閉合迴路給藥系統的轉變，預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球照護現場血糖檢測市場
• 按類型分類的細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 基於應用領域的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球照護現場血糖檢測市場
• 地緣政治衝突的影響：全球照護現場血糖檢測市場

第7章：五力分析

第8章 市場區隔：依類型

• 比較：按類型
• 條狀物
• 採血針及穿刺裝置
• 儀表
• 市場機會：按類型分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 居家醫療
• 診斷檢查室
• 其他
• 市場機會：依最終用戶分類

第10章 市場區隔：依應用

• 比較：按應用
• 2型糖尿病
• 1型糖尿病
• 妊娠糖尿病
• 其他
• 市場機會：依應用領域分類

第11章 客戶情況

第12章 區域情勢

• 區域分類
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 荷蘭
  • 西班牙
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 泰國
  • 印尼
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 南非
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• A. Menarini Diagnostics Srl
• Abbott Laboratories
• ACON Laboratories Inc.
• ARKRAY Inc.
• Ascensia Diabetes Care
• Bionime Corp.
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• I SENS Inc.
• LifeScan IP Holdings LLC
• Nipro Corp.
• Nova Biomedical Corp.
• Prodigy Diabetes Care LLC
• Siemens Healthineers AG
• Sinocare Inc.

第16章附錄

The global point of care glucose testing market is forecasted to grow by USD 993.2 mn during 2025-2030, accelerating at a CAGR of 5.1% during the forecast period. The report on the global point of care glucose testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of diabetes and metabolic disorders, expanding clinical adoption of continuous glucose monitoring, decentralization of healthcare services and outpatient care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global point of care glucose testing market is segmented as below:

By Type

• Strips
• Lancets and lancing devices
• Meters

By End-User

• Hospitals and clinics
• Home care settings
• Diagnostic laboratories
• Others

By Application

• Type 2 diabetes
• Type 1 diabetes
• Gestational diabetes
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the development of multi-analyte point of care sensors as one of the prime reasons driving the global point of care glucose testing market growth during the next few years. Also, integration of predictive ai and analytics and shift toward fully automated closed-loop delivery ecosystems will lead to sizable demand in the market.

The report on the global point of care glucose testing market covers the following areas:

• Global point of care glucose testing market sizing
• Global point of care glucose testing market forecast
• Global point of care glucose testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global point of care glucose testing market vendors that include A. Menarini Diagnostics S.r.l., Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care, Bionime Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., I SENS Inc., LifeScan IP Holdings LLC, Nipro Corp., Nova Biomedical Corp., Prodigy Diabetes Care LLC, PTS Diagnostics, Sensa Core Medical Instrumentation, Siemens Healthineers AG, Sinocare Inc., TaiDoc Technology Corp., Trivida Health Inc.. Also, the global point of care glucose testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Point Of Care Glucose Testing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Point Of Care Glucose Testing Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global point of care glucose testing market
• 6.2 Impact of geopolitical conflicts on global point of care glucose testing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Strips - Market size and forecast 2025-2030
• 8.4 Lancets and lancing devices - Market size and forecast 2025-2030
• 8.5 Meters - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2025-2030
• 9.4 Home care settings - Market size and forecast 2025-2030
• 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Type 2 diabetes - Market size and forecast 2025-2030
• 10.4 Type 1 diabetes - Market size and forecast 2025-2030
• 10.5 Gestational diabetes - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global prevalence of diabetes and metabolic disorders
  • Expanding clinical adoption of continuous glucose monitoring
  • Decentralization of healthcare services and outpatient care
• 13.2 Market challenges
  • Strict regulatory standards and complex product approval frameworks
  • Interference factors and analytical accuracy limitations
  • Data security risks and enterprise interoperability bottlenecks
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Development of multi-analyte point of care sensors
  • Integration of predictive AI and analytics
  • Shift toward fully automated closed-loop delivery ecosystems

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 A. Menarini Diagnostics S.r.l.
  • A. Menarini Diagnostics S.r.l. - Overview
  • A. Menarini Diagnostics S.r.l. - Product / Service
  • A. Menarini Diagnostics S.r.l. - Key offerings
  • SWOT
• 15.5 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.6 ACON Laboratories Inc.
  • ACON Laboratories Inc. - Overview
  • ACON Laboratories Inc. - Product / Service
  • ACON Laboratories Inc. - Key offerings
  • SWOT
• 15.7 ARKRAY Inc.
  • ARKRAY Inc. - Overview
  • ARKRAY Inc. - Product / Service
  • ARKRAY Inc. - Key offerings
  • SWOT
• 15.8 Ascensia Diabetes Care
  • Ascensia Diabetes Care - Overview
  • Ascensia Diabetes Care - Product / Service
  • Ascensia Diabetes Care - Key offerings
  • SWOT
• 15.9 Bionime Corp.
  • Bionime Corp. - Overview
  • Bionime Corp. - Product / Service
  • Bionime Corp. - Key offerings
  • SWOT
• 15.10 EKF Diagnostics Holdings Plc
  • EKF Diagnostics Holdings Plc - Overview
  • EKF Diagnostics Holdings Plc - Business segments
  • EKF Diagnostics Holdings Plc - Key offerings
  • EKF Diagnostics Holdings Plc - Segment focus
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 I SENS Inc.
  • I SENS Inc. - Overview
  • I SENS Inc. - Product / Service
  • I SENS Inc. - Key offerings
  • SWOT
• 15.13 LifeScan IP Holdings LLC
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product / Service
  • LifeScan IP Holdings LLC - Key offerings
  • SWOT
• 15.14 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.15 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.16 Prodigy Diabetes Care LLC
  • Prodigy Diabetes Care LLC - Overview
  • Prodigy Diabetes Care LLC - Product / Service
  • Prodigy Diabetes Care LLC - Key offerings
  • SWOT
• 15.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.18 Sinocare Inc.
  • Sinocare Inc. - Overview
  • Sinocare Inc. - Product / Service
  • Sinocare Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations